Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

about

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

Item

http://www.wikidata.org/entity/Q50854702

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

@en

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

@nl

type

Item

label

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

@en

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

@nl

prefLabel

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

@en

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

@nl

P1476

Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology

@en

P2093

Fengqian Li

http://www.w3.org/2001/XMLSchema#string

Jianping Qi

http://www.w3.org/2001/XMLSchema#string

Qin Yu

http://www.w3.org/2001/XMLSchema#string

Wei Wu

http://www.w3.org/2001/XMLSchema#string

Weili Zhao

http://www.w3.org/2001/XMLSchema#string

Xiaochun Dong

http://www.w3.org/2001/XMLSchema#string

Yunchang Xie

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Tian

http://www.w3.org/2001/XMLSchema#string

P2860

The big picture on nanomedicine: the state of investigational and approved nanomedicine products

Osmotically controlled oral drug delivery

Elementary osmotic pump

Modulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.

Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement

Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing.

Development of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of fenofibric acid in rat plasma.

Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia.

Nanomedicine: de novo design of nanodrugs.

P304

1988-1997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-016-1935-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yi Lu

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27161487

http://www.w3.org/2001/XMLSchema#string